DAIC

JUNE 18, 2024

FDA Breakthrough Device Designation accelerates the review process for novel technologies that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions, such as CAD, which impacts 7.8% Stent Related Adverse Events greater than 1 Year After PCI. of the U.S. population.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

DAIC

MARCH 20, 2024

CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally. degradation of magnesium observed 12 months after implantation in coronary arteries.4 2,3 It has shown 99.6%

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

Dr. Anish Koka

JULY 23, 2023

Most have gotten used to egregiously bad coverage of current events that fills the pages of today’s New York Times, but even by their now very low standards a recent telling of a story about peripheral artery disease was very bad. These payments made him one of the highest paid vascular surgeons in the country.

Vascular Care 52

Vascular Care Outpatient Peripheral Arterial Disease Stent 52